AT66143T - Solid preparation with slow release. - Google Patents

Solid preparation with slow release.

Info

Publication number
AT66143T
AT66143T AT85300215T AT85300215T AT66143T AT 66143 T AT66143 T AT 66143T AT 85300215 T AT85300215 T AT 85300215T AT 85300215 T AT85300215 T AT 85300215T AT 66143 T AT66143 T AT 66143T
Authority
AT
Austria
Prior art keywords
slow release
solid preparation
preparation
solid
slow
Prior art date
Application number
AT85300215T
Other languages
German (de)
Inventor
Rodney Dr Horder
Michel Dr Banks
Thomas Herbert Hoadley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to EP19850300215 priority Critical patent/EP0188040B1/en
Publication of AT66143T publication Critical patent/AT66143T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
AT85300215T 1985-01-11 1985-01-11 Solid preparation with slow release. AT66143T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19850300215 EP0188040B1 (en) 1985-01-11 1985-01-11 Slow release solid preparation

Publications (1)

Publication Number Publication Date
AT66143T true AT66143T (en) 1991-08-15

Family

ID=8194116

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85300215T AT66143T (en) 1985-01-11 1985-01-11 Solid preparation with slow release.

Country Status (7)

Country Link
US (1) US4842866A (en)
EP (1) EP0188040B1 (en)
AT (1) AT66143T (en)
CA (1) CA1273873A (en)
DE (1) DE3583799D1 (en)
ES (1) ES8705757A1 (en)
GR (1) GR860060B (en)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188040B1 (en) * 1985-01-11 1991-08-14 Abbott Laboratories Limited Slow release solid preparation
EP0250572A1 (en) * 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
CA1302659C (en) * 1986-10-24 1992-06-09 Hans-Peter K. Gribi Dental impression material
EP0275336A1 (en) * 1987-01-20 1988-07-27 Knoll Ag Pharmaceutical composition having a protracting effect
US5064736A (en) * 1988-03-23 1991-11-12 Olin Corporation Electrostatic method for multicolor imaging from a single toner bath
DE4002281C2 (en) * 1990-01-26 1992-09-10 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
NL9002008A (en) 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant DNA and RNA, and their derivatives.
FR2676364B1 (en) * 1991-05-17 1993-09-10 Lafon Labor A pharmaceutical composition based on derivatives of aminobutanone.
US5368862A (en) * 1991-12-18 1994-11-29 Merck & Co., Inc. Sustained release tablets containing alginate
US5411746A (en) * 1993-02-24 1995-05-02 Warner-Jenkinson Company, Inc. Dye compositions and methods for film coating tablets and the like
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
US6692766B1 (en) * 1994-06-15 2004-02-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Controlled release oral drug delivery system
DE4443358A1 (en) * 1994-12-06 1996-06-13 Basf Ag Depot drugs
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
US5811126A (en) * 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SI20108B (en) * 1997-06-11 2001-12-31 Abbott Lab A controlled release formulation for poorly soluble basic drugs
US6010718A (en) 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US20050064033A1 (en) * 1997-04-11 2005-03-24 Notario Gerard F. Extended release formulations of erythromycin derivatives
US6551616B1 (en) 1997-04-11 2003-04-22 Abbott Laboratories Extended release formulations of erythromycin derivatives
IN186245B (en) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
BG65116B1 (en) * 2000-01-06 2007-03-30 Abbott Laboratories Medicamentous form with controlled release of poorly soluble basic medicamentous forms
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US6642276B2 (en) * 2001-10-01 2003-11-04 M/S Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
WO2003037304A1 (en) * 2001-11-02 2003-05-08 Wockhardt Limited Controlled release compositions for macrolide antimicrobial agents
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
WO2003105810A1 (en) * 2002-06-14 2003-12-24 Andrx Corporation Pharmaceutical compositions for drugs having ph-dependentsolubility
SI21300A (en) * 2002-10-08 2004-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical compositions with alginates
US20100092562A1 (en) * 2002-11-26 2010-04-15 Hollenbeck R Gary Sustained-release drug delivery compositions and methods
GB0230034D0 (en) * 2002-12-23 2003-01-29 Biochemie Gmbh Organic compounds
US7063862B2 (en) * 2003-06-03 2006-06-20 Biokey, Inc. Pharmaceutical composition and method for treating
US7476403B2 (en) * 2003-06-16 2009-01-13 Andrx Pharmaceuticals, Llc Oral extended-release composition
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023184A2 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US20050053658A1 (en) * 2003-09-09 2005-03-10 Venkatesh Gopi M. Extended release systems for macrolide antibiotics
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
US20050084540A1 (en) * 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
JP2007522135A (en) 2004-01-30 2007-08-09 ザ ジョンズ ホプキンス ユニバーシティ Nitroxyl precursor compounds and methods of use
US20050260263A1 (en) * 2004-05-18 2005-11-24 Panion & Bf Biotech Inc. Sustained release formulation for sparingly soluble main drugs
CA2572223C (en) 2004-06-25 2014-08-12 The Johns Hopkins University Angiogenesis inhibitors
JP2008505124A (en) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション Pulse delivery tablets
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
EP1912635B1 (en) * 2005-07-29 2014-03-05 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Use of chk2 kinase inhibitors for cancer treatment
AU2006275702A1 (en) 2005-07-29 2007-02-08 Concert Pharmaceuticals Inc. Novel pharmaceutical compounds
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20070128272A1 (en) * 2005-12-07 2007-06-07 Zerbe Horst G Multi-vitamin and mineral supplement
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
RU2616292C2 (en) 2006-03-17 2017-04-14 Дзе Джонс Хопкинс Юниверсити N-hydroxilsulfonamide derivatives as new physiologically useful nitroxyl donors
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8551995B2 (en) 2007-01-19 2013-10-08 Xcovery Holding Company, Llc Kinase inhibitor compounds
AU2008304200B2 (en) * 2007-09-26 2013-12-19 Cardioxyl Pharmaceuticals, Inc. N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
AT518530T (en) * 2007-12-28 2011-08-15 Acraf Formulation with slow release based on a connection of glycogen and alginate
CA2723590C (en) 2008-05-07 2017-06-27 Cardioxyl Pharmaceuticals Inc. Novel nitroso compounds as nitroxyl donors and methods of use thereof
NZ590542A (en) 2008-06-19 2012-12-21 Xcovery Holding Co Llc Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
US8729097B2 (en) 2008-10-06 2014-05-20 The Johns Hopkins University Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disorders
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
JP5860811B2 (en) 2009-12-03 2016-02-16 オプコ ヘルス インコーポレイテッド Highly sulfated disaccharide preparation
ES2719101T3 (en) * 2009-12-07 2019-07-08 Univ Johns Hopkins N-acylated hydroxylamine derivatives and o-acylated hydroxylamine derivatives
CA2782248A1 (en) 2009-12-07 2011-06-16 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
US20120082720A1 (en) * 2010-10-05 2012-04-05 Sam Poon Ang Compositions For Treating Chronic Viral Infections
US20120082719A1 (en) * 2010-10-05 2012-04-05 Sam Poon Ang Compositions For Treating Chronic Viral Infections
ES2610226T3 (en) 2010-10-08 2017-04-26 Xcovery Holding Company Llc 6-Amino-pyridazin-3-yl-carboxamide compounds substituted as protein kinase modulators
KR102061537B1 (en) 2011-10-17 2020-01-03 더 존스 홉킨스 유니버시티 Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
WO2014070919A1 (en) 2012-11-01 2014-05-08 The Johns Hopkins University Controlled hno release through intramolecular cyclization-elimination
MX363843B (en) 2013-01-18 2019-04-05 Cardioxyl Pharmaceuticals Inc Pharmaceutical compositions comprising nitroxyl donors.
BR112015025460A2 (en) 2013-04-07 2017-10-10 Dana Farber Cancer Inst Inc custom cancer vaccine compositions and methods
ES2734060T3 (en) 2014-01-17 2019-12-04 Cardioxyl Pharmaceuticals Inc Nitroxyl donors of N-hydroxymethanesulfonamide
WO2015183839A1 (en) 2014-05-27 2015-12-03 Cardioxyl Pharmaceuticals, Inc. Pyrazolone derivatives as nitroxyl donors
US9464061B2 (en) 2014-05-27 2016-10-11 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives
WO2015183838A1 (en) 2014-05-27 2015-12-03 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives as nitroxyl donors
EP3234193A1 (en) 2014-12-19 2017-10-25 Massachusetts Institute of Technology Molecular biomarkers for cancer immunotherapy
US9782410B2 (en) 2015-06-09 2017-10-10 Rexahn Pharmaceuticals, Inc. Fluorocyclopentenylcytosine methods of use
KR101592144B1 (en) 2015-06-19 2016-02-04 고려대학교 산학협력단 An iodine capsule, method for manufacturing the same, and salt of comprising the same
US10383825B2 (en) 2015-08-13 2019-08-20 Temple University—Of the Commonwealth System of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
CA2994184A1 (en) 2015-09-04 2017-03-09 Rexahn Pharmaceuticals, Inc. Quinoxalinyl-piperazinamide methods of use
EP3446119A1 (en) 2016-04-18 2019-02-27 The Broad Institute Inc. Improved hla epitope prediction
WO2019211492A1 (en) 2018-05-04 2019-11-07 Tollys Tlr3 ligands that activate both epithelial and myeloid cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR985218A (en) * 1948-04-27 1951-07-16 Medical Alginates Ltd Improvements to the method of application of alginates products
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
DE2062715C3 (en) * 1970-12-19 1974-03-21 Efeka Friedrich & Kaufmann Arzneimittelfabrik, 3000 Hannover
EP0188040B1 (en) * 1985-01-11 1991-08-14 Abbott Laboratories Limited Slow release solid preparation
JP2971660B2 (en) * 1991-03-29 1999-11-08 株式会社東芝 Superconducting magnet apparatus
JP3000771B2 (en) * 1991-12-20 2000-01-17 株式会社日立製作所 Magnetically levitated running body and its running stabilization method

Also Published As

Publication number Publication date
EP0188040B1 (en) 1991-08-14
EP0188040A1 (en) 1986-07-23
US4842866A (en) 1989-06-27
GR860060B (en) 1986-05-12
ES550807D0 (en)
CA1273873A1 (en)
ES550807A0 (en) 1987-05-16
ES8705757A1 (en) 1987-05-16
CA1273873A (en) 1990-09-11
DE3583799D1 (en) 1991-09-19

Similar Documents

Publication Publication Date Title
AT53506T (en) Muenzenautomat.
AT74730T (en) Fluessigseifenspendersystem.
AT118528T (en) Brennstoffabrikate.
AT100260T (en) Duenndraht-vielfachanschlussstellenzwischenregenerator.
AT70718T (en) Pharmakadepotpraeparat.
AT44612T (en) Gefaesswaage.
AT69128T (en) Funkempfaenger.
AT65331T (en) Fluessigkristallanzeigevorrichtung.
AT52137T (en) Waermetauscher.
AT74239T (en) Rundsteuerempfaenger.
AT67823T (en) Kernbohrueberwachungssystem.
FI862049A0 (en) Vattentransportfordon with several stommar.
DE3875705T2 (en) Carbidopa-levodopa-composition with controlled release.
AT103046T (en) Kettenumschalteinrichtung.
DE3771091D1 (en) Formulation with a slow release.
AT55980T (en) 2-hydroxy-3-phenoxypropylamines.
DE3677145D1 (en) Mechanical befoerderungsgeraet.
AT74379T (en) Peptidplasminogenaktivatoren.
DE3785186T2 (en) Bindungsmolekuele with einzelpolypeptidkette.
DE3778441D1 (en) Fluessigkeitsspender with handausloesung.
DE3774021D1 (en) Kopiergeraet with fluessigentwicklung.
DE3783712D1 (en) Metallbandsaegeblatt with tripelspangeschliffenen karbideinsatzzaehnen.
AT31497T (en) Ratchenschluessel.
DE3680307D1 (en) Golfschlaegergriff weight with.
AT58798T (en) Flaechensicherung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time